1. Beetham WP. Filamentary Keratitis. Trans Am Ophthalmol Soc. 1935; 33:413–35.
2. Wright P. Filamentary keratitis. Trans Ophthalmol Soc U K. 1975; 95:260–6.
3. Albietz J, Sanfilippo P, Troutbeck R, Lenton LM. Management of filamentary keratitis associated with aqueous-deficient dry eye. Optom Vis Sci. 2003; 80:420–30.
Article
4. Diller R, Sant S. A case report and review of filamentary keratitis. Optometry. 2005; 76:30–6.
Article
5. Kakizaki H, Zako M, Mito H, Iwaki M. Filamentary keratitis improved by blepharoptosis surgery: two cases. Acta Ophthalmol Scand. 2003; 81:669–71.
Article
6. Tanioka H, Yokoi N, Komuro A, et al. Investigation of the corneal filament in filamentary keratitis. Invest Ophthalmol Vis Sci. 2009; 50:3696–702.
Article
7. Choi SK, Paek NH, Hong WS. Clinical observation of the filamentary keratitis. J Korean Ophthalmol Soc. 1974; 15:323–6.
8. Unal M, Sarici A. Filamentary keratopathy caused by corneal occlusion by large-angle paralytic strabismus. Cornea. 2006; 25:1105–6.
9. Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985; 103:347–50.
Article
10. Berke RN. Congenital ptosis; a classification of 200 cases. Arch Ophthal. 1949; 41:188–97.
11. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear micro-volumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978; 96:677–81.
Article
12. Gao J, Schwalb TA, Addeo JV, et al. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy. Cornea. 1998; 17:654–63.
13. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984; 27:459–61.
Article
14. Baum JL. The Castroviejo Lecture. Prolonged eyelid closure is a risk to the cornea. Cornea. 1997; 16:602–11.
15. Good WV, Whitcher JP. Filamentary keratitis caused by corneal occlusion in large-angle strabismus. Ophthalmic Surg. 1992; 23:66.
Article
16. Merjava S, Neuwirth A, Tanzerova M, Jirsova K. The spectrum of cytokeratins expressed in the adult human cornea, limbus and per-ilimbal conjunctiva. Histol Histopathol. 2011; 26:323–31.
17. Moore JC, Tiffany JM. Human ocular mucus. Chemical studies. Exp Eye Res. 1981; 33:203–12.
Article
18. Argüeso P, Spurr-Michaud S, Russo CL, et al. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci. 2003; 44:2487–95.
19. Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci. 1995; 36:1818–27.
20. Inatomi T, Spurr-Michaud S, Tisdale AS, et al. Expression of secre-tory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci. 1996; 37:1684–92.
21. Absolon MJ, Brown CA. Acetylcysteine in keratoconjunctivitis sicca. Br J Ophthalmol. 1968; 52:310–6.
Article
22. Hamilton W, Wood TO. Filamentary keratitis. Am J Ophthalmol. 1982; 93:466–9.
Article
23. Fayet B, Bernard JA, Ammar J, et al. Treatment of dry eye by tem-porary punctum plug. Comparison with a control group. J Fr Ophtalmol. 1990; 13:123–33.
24. Tuberville AW, Frederick WR, Wood TO. Punctal occlusion in tear deficiency syndromes. Ophthalmology. 1982; 89:1170–2.
Article
25. Gumus K, Lee S, Yen MT, Pflugfelder SC. Botulinum toxin injection for the management of refractory filamentary keratitis. Arch Ophthalmol. 2012; 130:446–50.
Article
26. Kitazawa K, Yokoi N, Watanabe A, et al. Eyelid surgery for refractory filamentary keratitis. Nihon Ganka Gakkai Zasshi. 2011; 115:693–8.